SCHEMBL25801459

SCHEMBL25801459

C=C/C=N\c1c(C)cccc1C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.35
GABRG2 P18507 2/20 0.35
GABRB3 P28472 2/20 0.35
LMNA P02545 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
GABRB2 P47870 2/20 0.35
HIF1A Q16665 2/20 0.35
FAAH O00519 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
HPGD P15428 1/20 0.35
GABRB1 P18505 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
HTR2C P28335 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20514370 0.89 GABRA1 (0.40) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL16471864 0.87 GABRA1 (0.39) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL5587268 0.84 GABRA1 (0.39) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL25847142 0.83 ATM (0.38) LMNACYP1A2TSHRCA1CA2
SCHEMBL5587011 0.82 GABRA1 (0.38) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL24023522 0.81 GABRA1 (0.34) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL14101206 0.80 CYP1A2 (0.39) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL22910258 0.79 GABRA1 (0.35) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL243957 0.77 GABRA1 (0.46) GABRA1GABRG2GABRB3LMNACYP1A2
SCHEMBL243958 0.77 GABRA1 (0.46) GABRA1GABRG2GABRB3LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133183-A1 KRAS INHIBITORS THERAS, INC. (US) 2023-07-13 WO disclosed
WO-2023133181-A1 KRAS INHIBITORS THERAS, INC. (US) 2023-07-13 WO disclosed